Discover 951 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 951
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
for
Tumor Hyperinsulinism (Tumor HI)
Location: Portland OR, Rochester MN, Chicago IL, Canton OH,
Sponsor: Rezolute
Sex: All
Age: 18+
Code: NCT06881992
Phase3, Recruiting
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
for
Opioid Use Disorder
Location: Portland OR
Sponsor: Boulder Care
Sex: All
Age: 18+
Code: NCT07169409
Phase1, Recruiting
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
for
Corneal Scar
Location: Portland OR, Loma Linda CA, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06257355
Phase1, Recruiting
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Portland OR, Loma Linda CA, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06452316
Phase1, Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Portland OR, Spokane WA, Sacramento CA,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
for
Fuchs Endothelial Dystrophy
Location: Portland OR
Sponsor: Michael D. Straiko, MD
Sex: All
Age: 30 - 70+
Code: NCT03813056
Phase2, Recruiting
Endoscopic Treatment of Intestinal Fistulas and Perforations
Endolumenal Partial Myotomy for the Treatment of Esophageal Achalasia
for
Achalasia
Location: Portland OR
Sponsor: The Oregon Clinic
Sex: All
Age: 18 - 70+
Code: NCT01302288
Phase2, Recruiting
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Portland OR, Eugene OR, Seattle WA, Mount Vernon WA,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Portland OR, Vancouver, Great Falls MT, Calgary,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Portland OR, Seattle WA, Gilbert AZ, Dallas TX,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase1, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
for
Extracorporeal Membrane Oxygenation Complication,
Location: Portland OR
Sponsor: Legacy Health System
Sex: All
Age: 18+
Code: NCT03965208
Recruiting
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
for
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Location: Portland OR, Bellevue WA, Oakland CA, Sherman Oaks CA,
Sponsor: Lighthouse Pharmaceuticals, Inc.
Sex: All
Age: 55 - 70+
Code: NCT06847321
Phase2, Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for
Non-small Cell Lung Cancer,
Location: Portland OR, Santa Monica CA, Duarte CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05877599
Phase1, Recruiting
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
for
Major Depressive Disorder
Location: Portland OR, Everett WA, Lafayette CA, Las Vegas NV,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06223880
Recruiting
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07654361
Phase3, Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for
Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,
Location: Portland OR, Irvine CA, Carlsbad CA, Chandler AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT07589595
Phase2, Recruiting
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Portland OR, Walnut Creek CA, Las Vegas NV,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07484217
Phase3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2